Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.

[1]  E. Kieff,et al.  Small molecule and peptide-mediated inhibition of Epstein-Barr virus nuclear antigen 1 dimerization. , 2012, Biochemical and biophysical research communications.

[2]  T. Kanda,et al.  DNA ligand designed to antagonize EBNA1 represses Epstein–Barr virus‐induced immortalization , 2011, Cancer science.

[3]  E. Kieff,et al.  Roscovitine Inhibits EBNA1 Serine 393 Phosphorylation, Nuclear Localization, Transcription, and Episome Maintenance , 2011, Journal of Virology.

[4]  P. Lieberman,et al.  Development of a High-Throughput Screen for Inhibitors of Epstein-Barr Virus EBNA1 , 2010, Journal of biomolecular screening.

[5]  Weiliang Zhu,et al.  Discovery of Selective Inhibitors Against EBNA1 via High Throughput In Silico Virtual Screening , 2010, PloS one.

[6]  I. Tempera,et al.  Regulation of Epstein-Barr Virus OriP Replication by Poly(ADP-Ribose) Polymerase 1 , 2010, Journal of Virology.

[7]  R. Burgess,et al.  Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism , 2010, Proceedings of the National Academy of Sciences.

[8]  Paul M. Lieberman,et al.  Role for G-Quadruplex RNA Binding by Epstein-Barr Virus Nuclear Antigen 1 in DNA Replication and Metaphase Chromosome Attachment , 2009, Journal of Virology.

[9]  S. Aras,et al.  Zinc Coordination Is Required for and Regulates Transcription Activation by Epstein-Barr Nuclear Antigen 1 , 2009, PLoS pathogens.

[10]  P. Desai,et al.  Protein Array Identification of Substrates of the Epstein-Barr Virus Protein Kinase BGLF4 , 2009, Journal of Virology.

[11]  N. Yamamoto,et al.  Induction of apoptosis in Epstein-Barr virus-infected B-lymphocytes by the NF-kappaB inhibitor DHMEQ. , 2008, Microbes and infection.

[12]  E. Kieff,et al.  Epstein-Barr Virus Nuclear Antigen 1 Does Not Cause Lymphoma in C57BL/6J Mice , 2008, Journal of Virology.

[13]  E. Flemington,et al.  siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells. , 2006, Virology.

[14]  Elliott Kieff,et al.  RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  章介 今井,et al.  Dominant-negative EBNA1によるEBウイルス腫瘍の抑制 , 2005 .

[16]  S. Clarke,et al.  In vitro and In vivo Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202 , 2005, Clinical Cancer Research.

[17]  H. Mizuguchi,et al.  Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  L. Schang.  Advances on cyclin-dependent kinases (CDKs) as novel targets for antiviral drugs. , 2005, Current drug targets. Infectious disorders.

[19]  E. Kieff,et al.  Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Imai,et al.  [Therapeutic inhibition of Epstein-Barr virus-associated tumor cell growth by dominant-negative EBNA1]. , 2005, Uirusu.

[21]  K. Tsuneyama,et al.  Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt’s lymphoma cells , 2005, Journal of Cancer Research and Clinical Oncology.

[22]  Christopher J. Ott,et al.  The Amino Terminus of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Contains AT Hooks That Facilitate the Replication and Partitioning of Latent EBV Genomes by Tethering Them to Cellular Chromosomes , 2004, Journal of Virology.

[23]  J. Kutok,et al.  Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host. , 2004, Blood.

[24]  Maria Kontoyianni,et al.  Evaluation of docking performance: comparative data on docking algorithms. , 2004, Journal of medicinal chemistry.

[25]  K. Takada,et al.  An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA , 1991, Virus Genes.

[26]  G. Wahl,et al.  Metaphase Chromosome Tethering Is Necessary for the DNA Synthesis and Maintenance of oriP Plasmids but Is Insufficient for Transcription Activation by Epstein-Barr Nuclear Antigen 1 , 2003, Journal of Virology.

[27]  L. Frappier,et al.  Separation of the DNA Replication, Segregation, and Transcriptional Activation Functions of Epstein-Barr Nuclear Antigen 1 , 2002, Journal of Virology.

[28]  M. Gulley,et al.  Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. , 2002, American journal of clinical pathology.

[29]  E. Kieff,et al.  Epstein–Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Lazzarin,et al.  Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain , 2001, AIDS (London).

[31]  E. Kieff,et al.  Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Piolot,et al.  Mapping EBNA-1 Domains Involved in Binding to Metaphase Chromosomes , 1999, Journal of Virology.

[33]  S. Burrows,et al.  X-Linked Agammaglobulinemia Patients Are Not Infected with Epstein-Barr Virus: Implications for the Biology of the Virus , 1999, Journal of Virology.

[34]  E. Bochkareva,et al.  The 2.2 A structure of a permanganate-sensitive DNA site bound by the Epstein-Barr virus origin binding protein, EBNA1. , 1998, Journal of molecular biology.

[35]  K. Takada,et al.  Epstein-Barr Virus Contributes to the Malignant Phenotype and to Apoptosis Resistance in Burkitt’s Lymphoma Cell Line Akata , 1998, Journal of Virology.

[36]  U. Arad.  Modified Hirt procedure for rapid purification of extrachromosomal DNA from mammalian cells. , 1998, BioTechniques.

[37]  C. Kim,et al.  B-lymphoblastoid cell lines from cancer patients , 1998, In Vitro Cellular & Developmental Biology - Animal.

[38]  R. Pfuetzner,et al.  Crystal Structure of the DNA-Binding Domain of the Epstein–Barr Virus Origin-Binding Protein, EBNA1, Bound to DNA , 1996, Cell.

[39]  R. Pfuetzner,et al.  Cooperative assembly of EBNA1 on the Epstein-Barr virus latent origin of replication , 1996, Journal of Virology.

[40]  E. Kieff.  Epstein-Barr virus and its replication , 1996 .

[41]  T. Lion,et al.  High-resolution FISH of the entire integrated Epstein-Barr virus genome on extended human DNA. , 1996, Cytogenetics and cell genetics.

[42]  R. Pfuetzner,et al.  Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA1 , 1995, Cell.

[43]  K. Takada,et al.  Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV , 1994, Journal of virology.

[44]  J. Lacy,et al.  Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells , 1994 .

[45]  L. Frappier,et al.  Stabilization of the EBNA1 protein on the Epstein-Barr virus latent origin of DNA replication by a DNA looping mechanism. , 1994, The Journal of biological chemistry.

[46]  M. Chamberlain,et al.  Expression of Epstein‐Barr virus proteins in primary CNS lymphoma in AIDS patients , 1993, Neurology.

[47]  L. Frappier,et al.  Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication , 1993, Journal of virology.

[48]  G. Hayward,et al.  Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions , 1992, Journal of virology.

[49]  R. Ambinder,et al.  Epstein-Barr virus in AIDS-related primary central nervous system lymphoma , 1991, The Lancet.

[50]  J. Lawrence,et al.  The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA , 1991, Journal of virology.

[51]  U. Nater,et al.  Epstein-Barr virus. , 1991, The Journal of family practice.

[52]  G. Hayward,et al.  Functional domains of Epstein-Barr virus nuclear antigen EBNA-1 , 1991, Journal of virology.

[53]  J. Mcneil,et al.  Genomic integration as a novel mechanism of EBV persistence. , 1990, Current topics in microbiology and immunology.

[54]  E. Kieff,et al.  Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. , 1989, The New England journal of medicine.

[55]  Robert H. Singer,et al.  Highly localized tracks of specific transcripts within interphase nuclei visualized by in situ hybridization , 1989, Cell.

[56]  L. Weiss,et al.  In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations. , 1989, The American journal of pathology.

[57]  J. Lawrence,et al.  Sensitive, high-resolution chromatin and chromosome mapping in situ: Presence and orientation of two closely integrated copies of EBV in a lymphoma line , 1988, Cell.

[58]  D. Reisman,et al.  trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1 , 1986, Molecular and cellular biology.

[59]  L. Young,et al.  EPSTEIN-BARR VIRUS RECEPTORS ON HUMAN PHARYNGEAL EPITHELIA , 1986, The Lancet.

[60]  G. Hayward,et al.  Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region , 1985, Cell.

[61]  J. Yates,et al.  A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus , 1985, Molecular and cellular biology.

[62]  J. Yates,et al.  Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells , 1985, Nature.

[63]  E. Kieff,et al.  Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA. , 1984, Science.

[64]  D. Reisman,et al.  A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[65]  N. Raab-Traub,et al.  Replication of Epstein–Barr virus in human epithelial cells infected in vitro , 1983, Nature.

[66]  E. Kieff,et al.  Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[67]  N. Day,et al.  Final case reporting from the ugandan prospective study of the relationship between ebv and burktit's lymphoma , 1982, International journal of cancer.

[68]  W. Henle,et al.  Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls. , 1978, IARC scientific publications.

[69]  T. Lindahl,et al.  Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[70]  G. Klein,et al.  Relationship between Epstein‐Barr virus (EBV) DNA and the EBV‐determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies , 1974, International journal of cancer.

[71]  J. Pagano,et al.  Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. , 1972, Nature: New biology.

[72]  B. Hirt.  Selective extraction of polyoma DNA from infected mouse cell cultures. , 1967, Journal of molecular biology.